---
schema_version: "secwatch.filing_event.v1"
accession: "0001835268-25-000044"
form_type: "8-K"
ticker: "CNTB"
cik: "0001835268"
company_name: "Connect Biopharma Holdings Ltd"
filed_at: "2025-07-21T23:59:59+00:00"
generated_at: "2026-05-18T05:14:57.568002+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# Connect Biopharma terminates ADR program; ordinary shares to list directly on Nasdaq under CNTB

## Summary
- On July 18, 2025, ordered termination of Deposit Agreement with Deutsche Bank Trust Company Americas.
- ADR program and Deposit Agreement expected to terminate on or about September 2, 2025.
- Each ADS (1 ordinary share) will be mandatorily cancelled and exchanged for ordinary shares 1:1.
- Company plans to list ordinary shares directly on Nasdaq under symbol CNTB after ADR termination.

## SEC filing metadata
- accession: 0001835268-25-000044
- form_type: 8-K
- ticker: CNTB
- cik: 0001835268
- company_name: Connect Biopharma Holdings Ltd
- filed_at: 2025-07-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 1.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1835268/000183526825000044/0001835268-25-000044-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1835268/000183526825000044/cntb-20250718.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001835268-25-000044
- JSON: https://secwatch.observer/filing/0001835268-25-000044.json
- Plain text: https://secwatch.observer/filing/0001835268-25-000044.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.